Deborah Cory-Slechta
Concepts (429)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Lead | 63 | 1979 | 55 |
Why?
| Behavior, Animal | 29 | 1979 | 77 |
Why?
| Prenatal Exposure Delayed Effects | 12 | 2004 | 46 |
Why?
| Lead Poisoning | 22 | 1979 | 32 |
Why?
| Dopamine | 29 | 1993 | 62 |
Why?
| Conditioning, Operant | 25 | 1979 | 17 |
Why?
| Paraquat | 13 | 1999 | 12 |
Why?
| Stress, Psychological | 7 | 2004 | 117 |
Why?
| Receptors, N-Methyl-D-Aspartate | 10 | 1994 | 38 |
Why?
| Environmental Pollutants | 8 | 2004 | 35 |
Why?
| Fungicides, Industrial | 9 | 2002 | 7 |
Why?
| Rats | 65 | 1979 | 530 |
Why?
| Nucleus Accumbens | 11 | 1994 | 12 |
Why?
| Maneb | 8 | 2000 | 4 |
Why?
| Environmental Exposure | 12 | 1990 | 75 |
Why?
| Motor Activity | 22 | 1986 | 104 |
Why?
| Triazoles | 5 | 2003 | 31 |
Why?
| Receptors, Dopamine D1 | 11 | 1991 | 3 |
Why?
| Animals | 110 | 1979 | 1031 |
Why?
| Dopamine Antagonists | 10 | 1995 | 11 |
Why?
| Dizocilpine Maleate | 10 | 1991 | 10 |
Why?
| Corticosterone | 8 | 2004 | 25 |
Why?
| Dopamine Agonists | 8 | 1994 | 14 |
Why?
| Herbicides | 8 | 1999 | 8 |
Why?
| Substantia Nigra | 9 | 1999 | 30 |
Why?
| Organometallic Compounds | 8 | 1979 | 40 |
Why?
| Brain | 22 | 1985 | 305 |
Why?
| Rats, Long-Evans | 14 | 1999 | 19 |
Why?
| Brain Chemistry | 10 | 1983 | 60 |
Why?
| Maternal Exposure | 5 | 2005 | 24 |
Why?
| Parkinson Disease | 9 | 2002 | 67 |
Why?
| Reinforcement Schedule | 15 | 1979 | 11 |
Why?
| Learning | 10 | 1989 | 66 |
Why?
| Male | 76 | 1979 | 1553 |
Why?
| Dose-Response Relationship, Drug | 27 | 1983 | 431 |
Why?
| Corpus Striatum | 9 | 1994 | 48 |
Why?
| Psychomotor Performance | 8 | 1989 | 69 |
Why?
| Benzazepines | 11 | 1989 | 12 |
Why?
| Hypothalamo-Hypophyseal System | 4 | 2005 | 25 |
Why?
| Nervous System Diseases | 5 | 1989 | 78 |
Why?
| Receptors, Dopamine | 6 | 1989 | 16 |
Why?
| Stress, Physiological | 3 | 2005 | 76 |
Why?
| N-Methylaspartate | 8 | 1991 | 18 |
Why?
| Pregnancy | 14 | 1996 | 455 |
Why?
| Aging | 10 | 1989 | 275 |
Why?
| Excitatory Amino Acid Antagonists | 6 | 1995 | 21 |
Why?
| Attention | 4 | 1998 | 64 |
Why?
| Receptors, Dopamine D2 | 7 | 1991 | 5 |
Why?
| Cognition Disorders | 5 | 1995 | 107 |
Why?
| Membrane Glycoproteins | 5 | 1996 | 154 |
Why?
| Serial Learning | 3 | 1994 | 5 |
Why?
| Body Weight | 15 | 1980 | 178 |
Why?
| Appetitive Behavior | 3 | 1997 | 3 |
Why?
| Parkinsonian Disorders | 3 | 2000 | 19 |
Why?
| Parkinson Disease, Secondary | 5 | 1999 | 17 |
Why?
| Receptors, AMPA | 2 | 2004 | 17 |
Why?
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 7 | 1989 | 2 |
Why?
| Mice, Inbred C57BL | 19 | 1999 | 318 |
Why?
| Apomorphine | 6 | 1989 | 8 |
Why?
| Time Factors | 21 | 1979 | 896 |
Why?
| Nerve Tissue Proteins | 7 | 1996 | 128 |
Why?
| Neostriatum | 4 | 1998 | 20 |
Why?
| Cognition | 8 | 1995 | 97 |
Why?
| Pesticides | 4 | 2003 | 10 |
Why?
| Environment | 2 | 2008 | 43 |
Why?
| Pituitary-Adrenal System | 2 | 2008 | 19 |
Why?
| Membrane Transport Proteins | 5 | 1996 | 43 |
Why?
| Neuropsychological Tests | 5 | 2000 | 113 |
Why?
| Mice | 28 | 1997 | 623 |
Why?
| Female | 30 | 1992 | 1643 |
Why?
| Animals, Newborn | 7 | 1992 | 175 |
Why?
| Discrimination Learning | 7 | 1989 | 20 |
Why?
| Biogenic Monoamines | 2 | 2005 | 2 |
Why?
| Central Nervous System | 3 | 2002 | 77 |
Why?
| Neurons | 11 | 1994 | 195 |
Why?
| Central Nervous System Agents | 1 | 2009 | 5 |
Why?
| Quinpirole | 7 | 1991 | 2 |
Why?
| Catecholamines | 2 | 2005 | 40 |
Why?
| Bone and Bones | 3 | 1987 | 99 |
Why?
| Memory Disorders | 1 | 2009 | 29 |
Why?
| Intelligence | 5 | 1995 | 43 |
Why?
| Sex Factors | 6 | 2004 | 284 |
Why?
| Serotonin | 6 | 2002 | 44 |
Why?
| Toxicity Tests | 3 | 1996 | 17 |
Why?
| Lead Poisoning, Nervous System, Childhood | 2 | 2004 | 3 |
Why?
| Nervous System | 4 | 1999 | 52 |
Why?
| Mental Recall | 2 | 1997 | 36 |
Why?
| Memory, Short-Term | 2 | 2004 | 13 |
Why?
| Tyrosine 3-Monooxygenase | 9 | 2000 | 30 |
Why?
| Risk | 1 | 2008 | 203 |
Why?
| Neurotransmitter Agents | 4 | 1995 | 30 |
Why?
| Random Allocation | 5 | 1994 | 160 |
Why?
| Maternal-Fetal Exchange | 4 | 2005 | 49 |
Why?
| Hazardous Substances | 1 | 2006 | 13 |
Why?
| Ergolines | 4 | 1991 | 4 |
Why?
| Prefrontal Cortex | 3 | 2000 | 13 |
Why?
| Memory | 5 | 1989 | 61 |
Why?
| Glutamic Acid | 2 | 2003 | 66 |
Why?
| Hippocampus | 7 | 1997 | 83 |
Why?
| Toxicology | 4 | 1987 | 26 |
Why?
| Cocaine | 3 | 1991 | 33 |
Why?
| Atrazine | 1 | 2005 | 2 |
Why?
| Sex Characteristics | 1 | 2006 | 85 |
Why?
| Neurotoxins | 2 | 1996 | 33 |
Why?
| Mental Disorders | 1 | 2008 | 132 |
Why?
| Dopamine Uptake Inhibitors | 1 | 2004 | 7 |
Why?
| Set (Psychology) | 1 | 2004 | 4 |
Why?
| Health Status | 1 | 2006 | 127 |
Why?
| Concept Formation | 1 | 2004 | 13 |
Why?
| Central Nervous System Stimulants | 1 | 2004 | 32 |
Why?
| Problem Solving | 1 | 2004 | 39 |
Why?
| Microinjections | 5 | 1997 | 30 |
Why?
| Drug Synergism | 5 | 1991 | 104 |
Why?
| Developmental Disabilities | 3 | 1995 | 54 |
Why?
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 1997 | 4 |
Why?
| Humans | 32 | 1993 | 1856 |
Why?
| Impulsive Behavior | 2 | 1998 | 11 |
Why?
| Risk Assessment | 5 | 1996 | 324 |
Why?
| Autoradiography | 4 | 1997 | 73 |
Why?
| Maternal Behavior | 1 | 2001 | 17 |
Why?
| Gene Expression Regulation | 1 | 2006 | 277 |
Why?
| Central Nervous System Diseases | 2 | 1996 | 33 |
Why?
| Nerve Growth Factor | 3 | 2000 | 20 |
Why?
| Tissue Distribution | 9 | 1980 | 124 |
Why?
| Cell Count | 5 | 2000 | 163 |
Why?
| Drinking | 3 | 1981 | 14 |
Why?
| Administration, Oral | 3 | 1996 | 170 |
Why?
| Phenotype | 6 | 1996 | 303 |
Why?
| Neural Pathways | 1 | 2000 | 48 |
Why?
| Discrimination (Psychology) | 2 | 1996 | 23 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 5 | 1996 | 17 |
Why?
| Drug Interactions | 4 | 1996 | 111 |
Why?
| Basal Ganglia | 1 | 2000 | 23 |
Why?
| Chelating Agents | 2 | 1988 | 45 |
Why?
| Edetic Acid | 2 | 1987 | 41 |
Why?
| Research Design | 4 | 1987 | 169 |
Why?
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1997 | 8 |
Why?
| Risk Factors | 8 | 1996 | 555 |
Why?
| Synaptic Transmission | 2 | 1997 | 58 |
Why?
| Piperazines | 3 | 1997 | 57 |
Why?
| Spatial Behavior | 2 | 1991 | 7 |
Why?
| Analysis of Variance | 5 | 1987 | 339 |
Why?
| Learning Disorders | 2 | 1995 | 32 |
Why?
| Injections, Intraperitoneal | 4 | 1996 | 57 |
Why?
| Carrier Proteins | 2 | 1996 | 177 |
Why?
| Spiperone | 1 | 1996 | 5 |
Why?
| Excitatory Amino Acid Agonists | 1 | 1996 | 27 |
Why?
| Lead Poisoning, Nervous System | 2 | 2003 | 1 |
Why?
| Dopamine Agents | 2 | 1991 | 19 |
Why?
| Drug Administration Schedule | 3 | 1997 | 191 |
Why?
| Intelligence Tests | 1 | 1995 | 22 |
Why?
| Neuroprotective Agents | 1 | 1997 | 60 |
Why?
| Infant | 7 | 1994 | 464 |
Why?
| Receptors, Cholinergic | 1 | 1995 | 15 |
Why?
| Quinolines | 3 | 1997 | 26 |
Why?
| Receptors, Muscarinic | 1 | 1995 | 16 |
Why?
| Reaction Time | 5 | 1986 | 81 |
Why?
| Chromatography, High Pressure Liquid | 3 | 2002 | 121 |
Why?
| 3,4-Dihydroxyphenylacetic Acid | 3 | 2000 | 11 |
Why?
| Remoxipride | 2 | 2004 | 1 |
Why?
| Age Factors | 3 | 1994 | 480 |
Why?
| Child, Preschool | 7 | 1994 | 554 |
Why?
| Organ Size | 5 | 1989 | 118 |
Why?
| Electrochemistry | 3 | 1998 | 32 |
Why?
| Air Pollutants | 1 | 1996 | 42 |
Why?
| Brain Mapping | 3 | 1997 | 61 |
Why?
| Neuronal Plasticity | 2 | 2004 | 46 |
Why?
| Space Perception | 2 | 2000 | 36 |
Why?
| Kidney | 5 | 1980 | 223 |
Why?
| Age Distribution | 1 | 1994 | 127 |
Why?
| Tyrosine | 1 | 1994 | 71 |
Why?
| Rats, Inbred F344 | 5 | 1989 | 80 |
Why?
| Child | 8 | 1994 | 749 |
Why?
| Haloperidol | 3 | 1991 | 16 |
Why?
| Scopolamine Hydrobromide | 1 | 1992 | 8 |
Why?
| Regression Analysis | 3 | 1989 | 256 |
Why?
| Limbic System | 2 | 2000 | 15 |
Why?
| Drosophila melanogaster | 1 | 1992 | 26 |
Why?
| Lung | 3 | 2000 | 232 |
Why?
| Orientation | 2 | 1999 | 29 |
Why?
| Reference Values | 3 | 1997 | 278 |
Why?
| Columbidae | 4 | 1979 | 11 |
Why?
| Principal Component Analysis | 2 | 2005 | 18 |
Why?
| Weaning | 3 | 1985 | 8 |
Why?
| Rats, Inbred Strains | 4 | 1981 | 170 |
Why?
| Reinforcement (Psychology) | 4 | 1983 | 14 |
Why?
| Salicylamides | 2 | 1999 | 2 |
Why?
| X-Rays | 1 | 2009 | 20 |
Why?
| Biological Markers | 2 | 2002 | 262 |
Why?
| Neurodegenerative Diseases | 2 | 2005 | 30 |
Why?
| Frontal Lobe | 1 | 2009 | 33 |
Why?
| Protoporphyrins | 4 | 1986 | 14 |
Why?
| Succimer | 1 | 1988 | 2 |
Why?
| Norepinephrine | 1 | 2009 | 68 |
Why?
| Arecoline | 3 | 1995 | 1 |
Why?
| Linear Models | 1 | 2009 | 151 |
Why?
| Alzheimer Disease | 2 | 2007 | 71 |
Why?
| Glutathione Peroxidase | 2 | 2005 | 24 |
Why?
| Amphetamine | 2 | 2002 | 11 |
Why?
| Sulfhydryl Compounds | 1 | 1988 | 42 |
Why?
| Geriatric Assessment | 1 | 2009 | 63 |
Why?
| Psychiatric Status Rating Scales | 1 | 2009 | 99 |
Why?
| 2-Amino-5-phosphonovalerate | 2 | 1997 | 4 |
Why?
| Cooperative Behavior | 1 | 2008 | 70 |
Why?
| Immunohistochemistry | 5 | 1997 | 355 |
Why?
| Dexamethasone | 1 | 2008 | 109 |
Why?
| Viral Proteins | 2 | 1997 | 71 |
Why?
| Osmolar Concentration | 2 | 1997 | 91 |
Why?
| Receptors, Dopamine D4 | 1 | 2007 | 1 |
Why?
| Cyanides | 1 | 2007 | 8 |
Why?
| Thioredoxin-Disulfide Reductase | 1 | 2007 | 5 |
Why?
| NADH, NADPH Oxidoreductases | 1 | 2007 | 14 |
Why?
| Pharmacokinetics | 1 | 2006 | 8 |
Why?
| Reproduction | 1 | 2006 | 21 |
Why?
| Epidemiologic Methods | 1 | 2006 | 46 |
Why?
| Cohort Studies | 3 | 2003 | 332 |
Why?
| Dextroamphetamine | 2 | 1991 | 12 |
Why?
| Cardiovascular System | 1 | 2006 | 40 |
Why?
| Phencyclidine | 2 | 1995 | 5 |
Why?
| Genetic Vectors | 4 | 1997 | 139 |
Why?
| Respiration | 1 | 2007 | 78 |
Why?
| Homovanillic Acid | 2 | 2002 | 19 |
Why?
| Gene Transfer Techniques | 3 | 2000 | 59 |
Why?
| Blotting, Western | 2 | 2005 | 275 |
Why?
| Body Burden | 3 | 1987 | 24 |
Why?
| Animals, Suckling | 2 | 1994 | 6 |
Why?
| Adrenal Cortex | 1 | 2005 | 11 |
Why?
| Microdialysis | 1 | 2005 | 6 |
Why?
| Receptors, Glucocorticoid | 1 | 2005 | 26 |
Why?
| Polymorphism, Genetic | 1 | 2007 | 94 |
Why?
| Longitudinal Studies | 1 | 1987 | 195 |
Why?
| Databases, Genetic | 1 | 2005 | 20 |
Why?
| Crop, Avian | 2 | 1980 | 1 |
Why?
| Superoxide Dismutase | 1 | 2005 | 46 |
Why?
| Mice, Inbred Strains | 1 | 2005 | 118 |
Why?
| Gliosis | 2 | 2000 | 14 |
Why?
| Mice, Transgenic | 6 | 1997 | 209 |
Why?
| Fracture Healing | 1 | 2005 | 23 |
Why?
| Binding Sites | 2 | 1996 | 213 |
Why?
| Chromosome Mapping | 1 | 2005 | 107 |
Why?
| Quinoxalines | 1 | 2004 | 9 |
Why?
| Mesencephalon | 4 | 2002 | 22 |
Why?
| Epithelial Cells | 1 | 2007 | 135 |
Why?
| Behavior | 2 | 1993 | 36 |
Why?
| Reproducibility of Results | 3 | 1993 | 391 |
Why?
| Substance Withdrawal Syndrome | 1 | 2004 | 24 |
Why?
| Nerve Net | 1 | 2004 | 23 |
Why?
| Glutamate Decarboxylase | 1 | 2003 | 13 |
Why?
| Child Development | 1 | 2006 | 49 |
Why?
| Kinetics | 2 | 1996 | 349 |
Why?
| Morphine | 2 | 1991 | 38 |
Why?
| Models, Animal | 1 | 2004 | 85 |
Why?
| Synaptosomes | 1 | 2003 | 7 |
Why?
| Thiocarbamates | 1 | 2003 | 9 |
Why?
| Disease Models, Animal | 2 | 2002 | 349 |
Why?
| Disease Susceptibility | 1 | 2003 | 61 |
Why?
| Drug Combinations | 1 | 2003 | 95 |
Why?
| Antioxidants | 1 | 2005 | 84 |
Why?
| Psychometrics | 1 | 2004 | 97 |
Why?
| Dimethyl Sulfoxide | 1 | 2002 | 30 |
Why?
| Lysosomal Storage Diseases | 1 | 2002 | 5 |
Why?
| Fetus | 1 | 2004 | 105 |
Why?
| Pentobarbital | 2 | 1991 | 16 |
Why?
| Immunodeficiency Virus, Feline | 1 | 2002 | 6 |
Why?
| Taste | 1 | 1981 | 10 |
Why?
| Nerve Degeneration | 1 | 2002 | 43 |
Why?
| Cerebral Cortex | 2 | 2000 | 108 |
Why?
| Heme Oxygenase (Decyclizing) | 2 | 1998 | 18 |
Why?
| Cadmium | 1 | 1981 | 30 |
Why?
| Pimozide | 1 | 2001 | 8 |
Why?
| Animals, Laboratory | 1 | 2001 | 8 |
Why?
| Septum of Brain | 1 | 2000 | 1 |
Why?
| Maze Learning | 1 | 2000 | 10 |
Why?
| Ventral Tegmental Area | 1 | 2000 | 9 |
Why?
| Integrases | 2 | 1997 | 36 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2000 | 37 |
Why?
| Clozapine | 1 | 2001 | 17 |
Why?
| Bird Diseases | 1 | 1980 | 1 |
Why?
| Social Behavior | 1 | 2001 | 53 |
Why?
| Infant, Newborn | 1 | 2005 | 389 |
Why?
| Child Behavior | 1 | 2000 | 41 |
Why?
| Models, Biological | 1 | 2005 | 410 |
Why?
| Motivation | 1 | 2001 | 85 |
Why?
| Lidocaine | 1 | 2000 | 49 |
Why?
| Motor Skills | 1 | 1979 | 28 |
Why?
| Photic Stimulation | 1 | 1999 | 58 |
Why?
| Pilot Projects | 2 | 1989 | 264 |
Why?
| NADPH Dehydrogenase | 1 | 1998 | 9 |
Why?
| Exploratory Behavior | 1 | 1998 | 15 |
Why?
| Potassium Chloride | 1 | 1998 | 42 |
Why?
| Reward | 1 | 1998 | 10 |
Why?
| Tritium | 1 | 1997 | 65 |
Why?
| Liver | 3 | 1980 | 248 |
Why?
| Mosaicism | 1 | 1997 | 13 |
Why?
| Herpesviridae | 1 | 1997 | 13 |
Why?
| Aged | 1 | 2009 | 988 |
Why?
| Sensitivity and Specificity | 2 | 1992 | 427 |
Why?
| Nerve Growth Factors | 1 | 1997 | 43 |
Why?
| Methylmercury Compounds | 1 | 1979 | 25 |
Why?
| Lactation | 1 | 1996 | 22 |
Why?
| Growth Plate | 1 | 1996 | 27 |
Why?
| Generalization, Stimulus | 1 | 1995 | 1 |
Why?
| Cholinergic Antagonists | 1 | 1995 | 5 |
Why?
| Muscarinic Agonists | 1 | 1995 | 15 |
Why?
| Middle Aged | 1 | 2009 | 1161 |
Why?
| Iron | 1 | 1996 | 75 |
Why?
| Receptors, Glutamate | 1 | 1994 | 13 |
Why?
| Socioeconomic Factors | 1 | 1996 | 144 |
Why?
| Bone Resorption | 1 | 1996 | 49 |
Why?
| Weight Gain | 1 | 1994 | 30 |
Why?
| Methyltyrosines | 1 | 1993 | 2 |
Why?
| alpha-Methyltyrosine | 1 | 1993 | 2 |
Why?
| Perfusion | 1 | 1994 | 73 |
Why?
| Drug Evaluation, Preclinical | 2 | 1989 | 65 |
Why?
| Habituation, Psychophysiologic | 2 | 2000 | 9 |
Why?
| Synucleins | 2 | 2002 | 4 |
Why?
| alpha-Synuclein | 2 | 2002 | 9 |
Why?
| Receptors, Dopamine D3 | 1 | 1992 | 1 |
Why?
| Cricetinae | 2 | 2000 | 130 |
Why?
| Chemical Precipitation | 1 | 1992 | 24 |
Why?
| Multivariate Analysis | 2 | 2003 | 225 |
Why?
| Fertility | 1 | 1992 | 32 |
Why?
| Generalization (Psychology) | 1 | 1991 | 7 |
Why?
| Mass Screening | 1 | 1994 | 125 |
Why?
| Cells, Cultured | 3 | 1996 | 447 |
Why?
| Heme Oxygenase-1 | 2 | 1998 | 28 |
Why?
| Choline O-Acetyltransferase | 2 | 2000 | 11 |
Why?
| Ditiocarb | 1 | 1990 | 8 |
Why?
| Oxidative Stress | 2 | 2005 | 119 |
Why?
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 1999 | 11 |
Why?
| Receptors, Opioid | 1 | 1991 | 16 |
Why?
| Receptors, Opioid, mu | 1 | 1991 | 15 |
Why?
| Death | 1 | 1990 | 21 |
Why?
| Transgenes | 2 | 1997 | 56 |
Why?
| Cell Survival | 2 | 1996 | 229 |
Why?
| Calcium | 1 | 1996 | 208 |
Why?
| Sensation | 1 | 1989 | 18 |
Why?
| Erythrocytes | 1 | 1990 | 109 |
Why?
| Sodium Chloride | 1 | 1989 | 77 |
Why?
| Confounding Factors (Epidemiology) | 1 | 2008 | 49 |
Why?
| Research | 1 | 2008 | 124 |
Why?
| Cricetulus | 1 | 2007 | 39 |
Why?
| Otoacoustic Emissions, Spontaneous | 1 | 2006 | 12 |
Why?
| CHO Cells | 1 | 2007 | 65 |
Why?
| Evoked Potentials | 1 | 2006 | 44 |
Why?
| Electrophysiology | 1 | 2007 | 101 |
Why?
| Statistics, Nonparametric | 1 | 2007 | 141 |
Why?
| ROC Curve | 1 | 2006 | 80 |
Why?
| In Situ Hybridization | 2 | 1996 | 135 |
Why?
| Tibia | 1 | 2005 | 34 |
Why?
| Auditory Perception | 1 | 2006 | 25 |
Why?
| Lipid Peroxidation | 1 | 2005 | 23 |
Why?
| Lipid Metabolism | 1 | 2005 | 50 |
Why?
| bcl-X Protein | 1 | 2005 | 32 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2005 | 39 |
Why?
| Mice, Inbred CBA | 1 | 2005 | 41 |
Why?
| Glutamate-Cysteine Ligase | 1 | 2005 | 17 |
Why?
| Chondrogenesis | 1 | 2005 | 17 |
Why?
| L-Lactate Dehydrogenase | 1 | 2005 | 59 |
Why?
| Enzyme Activation | 1 | 2007 | 177 |
Why?
| Muscle, Smooth | 1 | 1985 | 69 |
Why?
| Genetic Variation | 1 | 2005 | 91 |
Why?
| Immunoblotting | 1 | 2005 | 119 |
Why?
| Hydrogen Peroxide | 1 | 2005 | 75 |
Why?
| Blood-Brain Barrier | 1 | 1985 | 63 |
Why?
| Cartilage | 1 | 2005 | 33 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 71 |
Why?
| Adolescent | 2 | 2000 | 891 |
Why?
| Oxygen | 1 | 2007 | 179 |
Why?
| Ethylenebis(dithiocarbamates) | 1 | 2003 | 1 |
Why?
| Stanford-Binet Test | 1 | 2003 | 3 |
Why?
| Actins | 1 | 2005 | 112 |
Why?
| Organ Specificity | 1 | 2003 | 104 |
Why?
| Glutathione | 1 | 2005 | 65 |
Why?
| 1-Methyl-4-phenylpyridinium | 1 | 2002 | 2 |
Why?
| Mucopolysaccharidosis VII | 1 | 2002 | 3 |
Why?
| Glucuronidase | 1 | 2002 | 26 |
Why?
| Presynaptic Terminals | 1 | 2002 | 14 |
Why?
| Cell Line, Tumor | 1 | 2005 | 208 |
Why?
| Biological Transport | 1 | 2003 | 129 |
Why?
| Saccharin | 1 | 1981 | 5 |
Why?
| Osteoclasts | 1 | 2005 | 48 |
Why?
| Prospective Studies | 1 | 2007 | 545 |
Why?
| Solutions | 1 | 1981 | 54 |
Why?
| Models, Genetic | 1 | 2002 | 90 |
Why?
| gamma-Aminobutyric Acid | 1 | 2002 | 58 |
Why?
| Adult | 1 | 1996 | 1317 |
Why?
| Simplexvirus | 1 | 2000 | 33 |
Why?
| Mutagenesis, Insertional | 1 | 2000 | 37 |
Why?
| Organ Culture Techniques | 1 | 2000 | 42 |
Why?
| Mutagenesis, Site-Directed | 1 | 2002 | 126 |
Why?
| Mice, Mutant Strains | 1 | 2000 | 77 |
Why?
| Luminescent Proteins | 1 | 2000 | 67 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 135 |
Why?
| Disease Progression | 1 | 2002 | 244 |
Why?
| Green Fluorescent Proteins | 1 | 2000 | 105 |
Why?
| Embryo, Mammalian | 1 | 2000 | 99 |
Why?
| Retrospective Studies | 1 | 2006 | 653 |
Why?
| Genetic Predisposition to Disease | 1 | 2002 | 131 |
Why?
| Nerve Endings | 1 | 1999 | 12 |
Why?
| Polymerase Chain Reaction | 1 | 2002 | 279 |
Why?
| Promoter Regions, Genetic | 1 | 2002 | 188 |
Why?
| Apoptosis | 1 | 2005 | 265 |
Why?
| Cell Death | 1 | 1999 | 94 |
Why?
| Staining and Labeling | 1 | 1998 | 101 |
Why?
| 3T3 Cells | 1 | 1997 | 54 |
Why?
| Thymidine | 1 | 1996 | 47 |
Why?
| Gene Expression | 1 | 2000 | 291 |
Why?
| Proteoglycans | 1 | 1996 | 45 |
Why?
| Chickens | 1 | 1996 | 81 |
Why?
| Signal Transduction | 1 | 2005 | 313 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 224 |
Why?
| Collagen | 1 | 1996 | 118 |
Why?
| United States | 1 | 2003 | 604 |
Why?
| Recombinant Proteins | 1 | 1997 | 290 |
Why?
| Cell Division | 1 | 1996 | 273 |
Why?
| Membrane Proteins | 1 | 1998 | 233 |
Why?
| Escherichia coli | 1 | 1997 | 143 |
Why?
| Transcription, Genetic | 1 | 1997 | 253 |
Why?
| Practice Guidelines as Topic | 1 | 1994 | 174 |
Why?
| Spectrophotometry, Atomic | 1 | 1990 | 18 |
Why?
| Aminolevulinic Acid | 1 | 1990 | 10 |
Why?
| RNA, Messenger | 1 | 1998 | 394 |
Why?
| Ataxia | 1 | 1985 | 17 |
Why?
| Inclusion Bodies | 1 | 1985 | 20 |
Why?
| Cerebellum | 1 | 1985 | 59 |
Why?
| Culture Media | 1 | 1985 | 116 |
Why?
| Electric Stimulation | 1 | 1985 | 101 |
Why?
| Muscle Contraction | 1 | 1985 | 77 |
Why?
|
|
Cory-Slechta's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
